Alpha Tau Announces Presentation of Pancreatic Cancer Data at Upcoming ASCO Annual Meeting, Showcasing Combined Results from Three Alpha DaRT Pancreatic Cancer Studies

Abstract accepted at the American Society of Clinical Oncology (ASCO) Annual Meeting - the world’s largest and most prestigious medical ...

Tenaya Therapeutics Announces Late-Breaking Oral Presentation of New Clinical Data from RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy in Adults with PKP2 ...

Readout to Include One-Year Cohort 1 Results and Early Cohort 2 Data; Webcast Conference Call Planned to Review RIDGE-1 Data at ASGCT Additional ...
Yahoo Finance

Merus Announces Abstract Accepted for Presentation at the 2025 ASCO® Annual Meeting

UTRECHT, The Netherlands and CAMBRIDGE, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), an oncology company developing innovative, full-length ...
WIBW

Governor’s Water Conference officials invite researchers to submit abstracts for presentation

TOPEKA, Kan. (WIBW) - The Governor’s Water Conference will highlight the latest policy and research developments on water issues in Kansas. According to the Kansas Water Office, the 13th annual ...

Bridge to Life Announces Oral and Poster Presentations at The 2026 International Congress of the International Liver Transplantation Society (ILTS) in Geneva, Switzerland, May ...

Bridge to Life™ Ltd., a global innovator in organ preservation solutions and perfusion technology, today announced the presentation of 12 accepted abstracts (five oral, including one Plenary Session ...
iaea.org

International Conference on Hybrid Imaging (IPET 2024) - Abstract and Paper Submissions

Contributions on the topics listed in the Conference Announcement under Section C are welcome as oral or poster presentations. All submissions, apart from invited papers, must present original work, ...
Seeking Alpha

Verastem Oncology Announces Late Breaking and Regular Abstracts Accepted for Presentation at the AACR Annual Meeting 2026

Preclinical research with VS-7375 in combination with PRMT5 inhibitors demonstrated strong durable tumor regressions in KRAS G12D pancreatic cancer models In preclinical pancreatic, lung, and ...